Back

Subcutaneous delivery of NPA7, first-in-class novel bispecific designer peptide: enhances cardiorenal function and suppresses renin and aldosterone in vivo and in vitro

3 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 7 - Heart Failure Basic Science Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Associate Professor Shinobu Sugihara

Shimane University, Matsue (Japan)

8 More presentations in this session

Presentation thumbnail
Doctor B. Ferguson (South San Francisco, US)
Abstract Slides
Presentation thumbnail
Doctor M. Elkenani (Gottingen, DE)
Abstract Slides
Presentation thumbnail
Professor M. Franz (Rotenburg an der Fulda, DE)
Abstract
Presentation thumbnail
Doctor I. Schaefer (Basel, CH)
Abstract
Presentation thumbnail
Professor L. Yu (Wuhan, CN)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 7 - Heart Failure Basic Science

The Event

Event poster

ESC Congress 2019

3 September 2019 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Dipeptidyl peptidase-3, a marker of the antagonist pathway of the renin-angiotensin-aldosterone system in patients with heart failure
30 June 2021
thumbnail
Congress Presentation
A soluble guanylate cyclase stimulator improves survival in a rat model of heart failure with reduced ejection fraction and chronic kidney disease induced by aorto-caval fistula and 5/6 nephrectomy
1 September 2025
thumbnail
Congress Presentation
Results from a phase 1 multiple ascending dose study demonstrating safety and selectivity of aldosterone synthase inhibitor CIN-107
28 August 2022
thumbnail
Congress Presentation
Natriuretic response following an infusion of subcutaneous furosemide in patients with worsening heart failure
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources